[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB9605293D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB9605293D0
GB9605293D0 GBGB9605293.1A GB9605293A GB9605293D0 GB 9605293 D0 GB9605293 D0 GB 9605293D0 GB 9605293 A GB9605293 A GB 9605293A GB 9605293 D0 GB9605293 D0 GB 9605293D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9605293.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9605293.1A priority Critical patent/GB9605293D0/en
Publication of GB9605293D0 publication Critical patent/GB9605293D0/en
Priority to PCT/EP1997/001236 priority patent/WO1997033565A1/en
Priority to AU21552/97A priority patent/AU2155297A/en
Pending legal-status Critical Current

Links

GBGB9605293.1A 1996-03-13 1996-03-13 Medicaments Pending GB9605293D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9605293.1A GB9605293D0 (en) 1996-03-13 1996-03-13 Medicaments
PCT/EP1997/001236 WO1997033565A1 (en) 1996-03-13 1997-03-12 Nucleoside compositions containing paracellular absorption enhancers
AU21552/97A AU2155297A (en) 1996-03-13 1997-03-12 Nucleoside compositions containing paracellular absorption enhancers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9605293.1A GB9605293D0 (en) 1996-03-13 1996-03-13 Medicaments

Publications (1)

Publication Number Publication Date
GB9605293D0 true GB9605293D0 (en) 1996-05-15

Family

ID=10790327

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9605293.1A Pending GB9605293D0 (en) 1996-03-13 1996-03-13 Medicaments

Country Status (3)

Country Link
AU (1) AU2155297A (en)
GB (1) GB9605293D0 (en)
WO (1) WO1997033565A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
GB2470494B (en) * 2008-01-17 2012-08-08 Univ Holy Ghost Duquesne Antiretroviral drug formulations for treatment of children exposed to HIV/AIDS
UY34402A (en) 2011-10-21 2013-05-31 Abbvie Inc METHODS FOR HCV TREATMENT
US8809265B2 (en) 2011-10-21 2014-08-19 Abbvie Inc. Methods for treating HCV
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
CN103908466A (en) * 2012-12-29 2014-07-09 安徽贝克生物制药有限公司 Zidovudine and lamivudine capsule and preparation method thereof
RU2587782C1 (en) * 2015-01-19 2016-06-20 Общество с ограниченной ответственностью "Трейдсервис" Stable pharmaceutical composition lamivudine
EP3448392A4 (en) 2016-04-28 2020-01-15 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
JP2831030B2 (en) * 1989-05-12 1998-12-02 学校法人城西大学 Composition for transdermal administration preparation containing 3'-azido-3'deoxythymidine as active ingredient
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int Pharmaceutical compositions containing cis-4-amino-1(hydroxymethyl-1,3-oxathiolan-5-yl)-1H-pyrimid-2-one nucleoside or its derivatives
CA2106483A1 (en) * 1991-03-19 1992-09-20 Vithal J. Rajadhyaksha Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
EP0663831A1 (en) * 1991-12-13 1995-07-26 G.D. Searle & Co. Transdermal azidothymidine
GB9418530D0 (en) * 1994-09-14 1994-11-02 Glaxo Group Ltd Medicaments
GB9517022D0 (en) * 1995-08-19 1995-10-25 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
WO1997033565A1 (en) 1997-09-18
AU2155297A (en) 1997-10-01

Similar Documents

Publication Publication Date Title
GB9606805D0 (en) Medicaments
HUP0003750A3 (en) Medicaments
GB9419536D0 (en) Medicaments
GB9406573D0 (en) Medicaments
GB9702021D0 (en) Medicaments
GB9718791D0 (en) Medicaments
GB9420784D0 (en) Medicaments
GB9618974D0 (en) Medicaments
GB9611947D0 (en) Medicaments
GB9605293D0 (en) Medicaments
GB9418530D0 (en) Medicaments
GB9411052D0 (en) Medicaments
GB9611167D0 (en) Medicaments
GB9416365D0 (en) Medicaments
GB9613096D0 (en) Medicaments
EP0790829A4 (en) Medicaments
GB9605292D0 (en) Medicaments
GB9600641D0 (en) Medicaments
GB9605291D0 (en) Medicaments
GB9605329D0 (en) Medicaments
GB9623160D0 (en) Medicaments
GB9618975D0 (en) Medicaments
GB9605859D0 (en) Medicaments
GB9605328D0 (en) Medicaments
GB9605305D0 (en) Medicaments